Short answer
Jabil (JBL) filed its fiscal 2026 10-K annual report with the SEC on Oct 23, 2026. It reported revenue of $36.0B (+20.6% year over year) and net income of $1.0B.
- Top risk flagged: FDA Warning Letter, August 2026: Pharmaceutics International facility manufacturing paused pending remediation of quality-system findings
FY2026 key financial metrics · XBRL
- Revenue
- $36.0B
- +20.6% YoY
- Net income
- $1.0B
- +58.6% YoY
- Operating margin
- 4.7%
- +0.8 pp YoY
- Gross margin
- 9.2%
- +0.3 pp YoY
- EPS (diluted)
- $9.75
- +64.7% YoY
- ROE
- 64.6%
- +21.2 pp YoY
- Operating cash flow
- $2.0B
- +22.1% YoY
Source: XBRL data from the Jabil (JBL) FY2026 10-K on SEC EDGAR. USD.
Jabil FY2026 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Global engineering, supply chain, and manufacturing partner managing customers’ product lifecycles across industries
- Segment renamed Intelligent Devices and Robotics, emphasizing automation, robotics, and more complex engineered solutions
- AI-driven supply-chain orchestration, procurement intelligence, and employee AI capability development newly emphasized
- $36.0 billion revenue and $1.0 billion net income, with operations across approximately 120 locations in 30 countries
- Over 4,400 employees recognized, a 66% increase from the prior fiscal year
Management Discussion & Analysis
- Revenue $35,954M, up 20.6% YoY, driven by Intelligent Infrastructure revenue growth of 45%
- Gross margin 9.2% vs 8.9%, operating margin 4.7% vs 4.0%, core operating margin 5.8% vs 5.4%
- Best segment: Intelligent Infrastructure, revenue up 45%; worst: Connected Living and Digital Commerce, revenue down 4%
- Operating cash flow $2,002M, adjusted free cash flow $1,532M, capex $628M
- Dividends paid $1,060M, share repurchases $1,000M, fiscal 2027 capex outlook 1.5% to 2.0% of net revenue
Risk Factors
- FDA Warning Letter, August 2026: Pharmaceutics International facility manufacturing paused pending remediation of quality-system findings
- China exposure: significant manufacturing, design, support, and storage operations subject to tariffs, political differences, and evolving Chinese regulations
- Global memory component shortage: current supply-chain impact threatens production, costs, and inventory obsolescence
- Competition from diversified electronic manufacturing service providers: greater resources, vertical capabilities, and pricing power intensify margin pressure
- Customer concentration: reduced sales or insolvency of a major customer could materially reduce revenue and increase inventory write-offs
Generated from the filing text; verify against the original. How to read a 10-K
Other Jabil annual reports
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.